Articles

Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients

Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Oncotherapeutics, West Hollywood, CA, USA
Oncotherapeutics, West Hollywood, CA, USA
Oncotherapeutics, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
James R. Berenson, MD, Inc., West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA, USA;Oncotherapeutics, West Hollywood, CA, USA;James R. Berenson, MD, Inc., West Hollywood, CA, USA
Vol. 102 No. 4 (2017): April, 2017 https://doi.org/10.3324/haematol.2016.150896